Sciety

Pathogen Reduction of SARS-CoV-2 Virus in Plasma and Whole Blood using Riboflavin and UV Light

This article has 5 authors:
1. Izabela Ragan
2. Lindsay Hartson
3. Heather Pidcoke
4. Richard Bowen
5. Raymond P. Goodrich
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version May 4, 2020Latest activity Jun 6, 2020
PSGL-1 inhibits the virion incorporation of SARS-CoV and SARS-CoV-2 spike glycoproteins and impairs virus attachment and infectivity

This article has 8 authors:
1. Sijia He
2. Abdul A. Waheed
3. Brian Hetrick
4. Deemah Dabbagh
5. Ivan V. Akhrymuk
6. Kylene Kehn-Hall
7. Eric O. Freed
8. Yuntao Wu
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version May 2, 2020Latest activity Jun 6, 2020
Release of potential pro-inflammatory peptides from SARS-CoV-2 spike glycoproteins in neutrophil-extracellular traps

This article has 2 authors:
1. Aitor Blanco-Míguez
2. Borja Sánchez
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version May 2, 2020Latest activity Jun 6, 2020
Identification of Drugs Blocking SARS-CoV-2 Infection using Human Pluripotent Stem Cell-derived Colonic Organoids

This article has 19 authors:
1. Xiaohua Duan
2. Yuling Han
3. Liuliu Yang
4. Benjamin E. Nilsson-Payant
5. Pengfei Wang
6. Tuo Zhang
7. Jenny Xiang
8. Dong Xu
9. Xing Wang
10. Skyler Uhl
11. Yaoxing Huang
12. Huanhuan Joyce Chen
13. Hui Wang
14. Benjamin tenOever
15. Robert E. Schwartz
16. David. D. Ho
17. Todd Evans
18. Fong Cheng Pan
19. Shuibing Chen
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version May 2, 2020Latest activity Jun 6, 2020
Comparative transcriptome analysis reveals the intensive early-stage responses of host cells to SARS-CoV-2 infection

This article has 12 authors:
1. Jiya Sun
2. Fei Ye
3. Aiping Wu
4. Ren Yang
5. Mei Pan
6. Jie Sheng
7. Wenjie Zhu
8. Longfei Mao
9. Ming Wang
10. Baoying Huang
11. Wenjie Tan
12. Taijiao Jiang
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version May 1, 2020Latest activity Jun 6, 2020
Protoporphyrin IX and verteporfin prevent SARS-CoV-2 infection in vitro and in a mouse model expressing human ACE2

This article has 17 authors:
1. Chenjian Gu
2. Yang Wu
3. Huimin Guo
4. Yuanfei Zhu
5. Wei Xu
6. Yuyan Wang
7. Yu Zhou
8. Zhiping Sun
9. Xia Cai
10. Yutang Li
11. Jing Liu
12. Zhong Huang
13. Zhenghong Yuan
14. Rong Zhang
15. Qiang Deng
16. Di Qu
17. Youhua Xie
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version May 1, 2020Latest activity Jun 6, 2020
Dysregulation in mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells

This article has 14 authors:
1. Sofia Appelberg
2. Soham Gupta
3. Anoop T Ambikan
4. Flora Mikaeloff
5. Ákos Végvári
6. Sara Svensson Akusjärvi
7. Rui Benfeitas
8. Maike Sperk
9. Marie Ståhlberg
10. Shuba Krishnan
11. Kamal Singh
12. Josef M. Penninger
13. Ali Mirazimi
14. Ujjwal Neogi
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version May 1, 2020Latest activity Jun 6, 2020
Broad-spectrum antiviral activity of naproxen: from Influenza A to SARS-CoV-2 Coronavirus

This article has 12 authors:
1. Olivier Terrier
2. Sébastien Dilly
3. Andrés Pizzorno
4. Julien Henri
5. Francis Berenbaum
6. Bruno Lina
7. Bruno Fève
8. Frédéric Adnet
9. Michèle Sabbah
10. Manuel Rosa-Calatrava
11. Vincent Maréchal
12. Anny Slama Schwok
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version May 1, 2020Latest activity Jun 6, 2020
Distinct Inductions of and Responses to Type I and Type III Interferons Promote Infections in Two SARS-CoV-2 Isolates

This article has 12 authors:
1. Fu Hsin
2. Tai-Ling Chao
3. Yun-Rui Chan
4. Han-Chieh Kao
5. Wang-Da Liu
6. Jann-Tay Wang
7. Yu-Hao Pang
8. Chih-Hui Lin
9. Ya-Min Tsai
10. Jing-Yi Lin
11. Sui-Yuan Chang
12. Helene Minyi Liu
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version May 1, 2020Latest activity Jun 6, 2020
Rampant C->U hypermutation in the genomes of SARS-CoV-2 and other coronaviruses – causes and consequences for their short and long evolutionary trajectories

This article has 1 author:
1. P. Simmonds
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version May 1, 2020Latest activity Jun 6, 2020

Previous Page 67 of 251 Next

Microbiology

Pathogen Reduction of SARS-CoV-2 Virus in Plasma and Whole Blood using Riboflavin and UV Light

PSGL-1 inhibits the virion incorporation of SARS-CoV and SARS-CoV-2 spike glycoproteins and impairs virus attachment and infectivity

Release of potential pro-inflammatory peptides from SARS-CoV-2 spike glycoproteins in neutrophil-extracellular traps

Identification of Drugs Blocking SARS-CoV-2 Infection using Human Pluripotent Stem Cell-derived Colonic Organoids

Comparative transcriptome analysis reveals the intensive early-stage responses of host cells to SARS-CoV-2 infection

Protoporphyrin IX and verteporfin prevent SARS-CoV-2 infection in vitro and in a mouse model expressing human ACE2

Dysregulation in mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells

Broad-spectrum antiviral activity of naproxen: from Influenza A to SARS-CoV-2 Coronavirus

Distinct Inductions of and Responses to Type I and Type III Interferons Promote Infections in Two SARS-CoV-2 Isolates

Rampant C->U hypermutation in the genomes of SARS-CoV-2 and other coronaviruses – causes and consequences for their short and long evolutionary trajectories